Aridis Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aridis Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2023.
  • Aridis Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $1.07M, a 30% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $1.07M -$459K -30% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $1.19M -$459K -27.9% Jun 30, 2023 10-Q 2023-09-14
Q1 2023 $1.3M -$460K -26.1% Mar 31, 2023 10-Q 2023-06-08
Q4 2022 $1.42M -$483K -25.4% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 $1.53M Sep 30, 2022 10-K 2023-05-22
Q2 2022 $1.65M Jun 30, 2022 10-K 2023-05-22
Q1 2022 $1.76M Mar 31, 2022 10-K 2023-05-22
Q4 2021 $1.9M Jan 1, 2022 10-Q 2023-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.